| 000 | 01225 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250515143805.0 | ||
| 264 | 0 | _c20081201 | |
| 008 | 200812s 0 0 eng d | ||
| 022 | _a1474-4422 | ||
| 024 | 7 |
_a10.1016/S1474-4422(08)70230-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDonnan, Geoffrey A | |
| 245 | 0 | 0 |
_aBreaking the 3 h barrier for treatment of acute ischaemic stroke. _h[electronic resource] |
| 260 |
_bThe Lancet. Neurology _cNov 2008 |
||
| 300 |
_a981-2 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aBrain Ischemia _xdrug therapy |
| 650 | 0 | 4 | _aClinical Protocols |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xstandards |
| 650 | 0 | 4 | _aEarly Diagnosis |
| 650 | 0 | 4 |
_aEmergency Medical Services _xstandards |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xstandards |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aStroke _xdrug therapy |
| 650 | 0 | 4 |
_aThrombolytic Therapy _xstandards |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xstandards |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aDavis, Stephen M | |
| 773 | 0 |
_tThe Lancet. Neurology _gvol. 7 _gno. 11 _gp. 981-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1474-4422(08)70230-8 _zAvailable from publisher's website |
| 999 |
_c18403765 _d18403765 |
||